We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.28B
AUM Growth
+$52.4M
Cap. Flow
+$14.6M
Cap. Flow %
1.14%
Top 10 Hldgs %
76.61%
Holding
30
New
Increased
4
Reduced
24
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 25.2%
2 Communication Services 21.65%
3 Healthcare 12.69%
4 Consumer Discretionary 10.48%
5 Consumer Staples 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
26
CALL
iShares Russell 2000 ETF
IWM
$80.2B
-89,300
Closed -$24.2M

Similar funds

Bronte Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bronte Capital Management held 30 positions worth $1.28B, up 4.3% from $1.23B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Bronte Capital Management's Q2 2024 filing shows 4 increased, 24 reduced and 2 closed positions. The largest sale was Alphabet (Google) Class A, an estimated $9.79M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Communication Services and Healthcare.

  • Bronte Capital Management added most to iShares Core S&P Small-Cap ETF in Q2 2024, an estimated $62.2M increase.
  • Bronte Capital Management's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $9.79M.
  • Bronte Capital Management fully exited CytomX Therapeutics in Q2 2024, selling an estimated $1.98M.
  • Bronte Capital Management's ten largest holdings make up 77% of its $1.28B portfolio in Q2 2024.
  • Bronte Capital Management opened 0 new positions and closed 2 in Q2 2024.
  • Bronte Capital Management's portfolio value rose 4.3% quarter-over-quarter to $1.28B.

Based on Bronte Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.